Results 41 to 50 of about 378 (110)

Pathophysiology, Treatment, and Prognosis of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome: A Review. [PDF]

open access: yesCurr Issues Mol Biol
TAFRO syndrome, first reported in 2010, is a systemic inflammatory disease with a rapid onset and potentially fatal course if not treated promptly and appropriately.
Kakutani T, Kamada R, Tamai Y.
europepmc   +2 more sources

Case report: A case of acute exacerbation of interstitial pneumonia associated with TAFRO syndrome [PDF]

open access: yes, 2023
Cytokine storm caused by the overproduction of inflammatory interleukin (IL)-6 plays a central role in the development of acute inflammation. The extremely rare disease, TAFRO syndrome, progresses quickly.
Eri Shishido   +7 more
core   +1 more source

TAFRO syndrome was effectively treated with an inexpensive novel scheme: A case report

open access: yesClinical Case Reports, Volume 11, Issue 2, February 2023., 2023
The combination of methylprednisolone and mycophenolate mofetil is effective for TAFRO syndrome. Abstract A man diagnosed as TAFRO syndrome was successfully responded to a novel immunosuppressive regimen containing methylprednisolone and mycophenolate mofetil. Blood cells firstly recovered, followed by the general situation and complete recover 1 month
Shan Meng   +7 more
wiley   +1 more source

A clinical, histological and transcriptomic characterization of a selected series of Castleman disease’s cases [PDF]

open access: yes, 2023
Castleman disease (CD) is a rare lymphoproliferative disorder that includes various clinico-pathological subtypes. According to clinical course CD is divided in unicentric CD (UCD) and multicentric CD (MCD).
FRATICELLI, SARA
core  

Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis

open access: yeseJHaem, 2022
Castleman disease (CD) is a rare lymphoproliferative disorder with multiple subtypes. Thrombocytopenia, anasarca, fever, reticulin fibrosis or renal insufficiency, and organomegaly (TAFRO) syndrome can occur in the context of CD.
Yoshito Nishimura   +5 more
doaj   +1 more source

Idiopathic multicentric Castleman disease in an adolescent diagnosed following COVID‐19 infection

open access: yes, 2023
Pediatric Blood &Cancer, Volume 70, Issue 6, June 2023.
Eman Mosleh   +5 more
wiley   +1 more source

Lymphadenopathy in the rheumatology practice: a pragmatic approach [PDF]

open access: yes, 2023
Lymphadenopathy is a common clinical finding and diagnostic challenge within general medicine and rheumatology practice. It may represent a primary manifestation of an underlying immune-mediated disease or indicate an infectious or neoplastic ...
Bongiovanni, Lucia   +5 more
core  

TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature

open access: yesFrontiers in Medicine, 2017
BackgroundTAFRO syndrome has been reported in Japan among human herpesvirus 8 (HHV-8)-negative/idiopathic multicentric Castleman’s disease (iMCD) patients.
Céline Louis   +8 more
doaj   +1 more source

Spontaneous remission of iMCD-TAFRO: a case report

open access: yesAnnals of Hematology
Idiopathic multicentric Castleman disease (iMCD)- TAFRO (thrombocytopenia, ascites, fever, reticulin fibrosis and organomegaly) is a clinically severe situation characterized by cytokine storms that are potentially fatal, necessitating prompt and decisive medical intervention.
Yuchong Qiu   +4 more
openaire   +2 more sources

Computed tomography findings of idiopathic multicentric Castleman disease subtypes [PDF]

open access: yes
This study retrospectively evaluated the computed tomography (CT) findings of idiopathic multicentric Castleman disease (iMCD) at a single center and compared the CT findings of iMCD-TAFRO with those of iMCD-non-TAFRO.
Asahara, Takashi   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy